Hot Topics: Research Ethics

Blog Posts (61)

September 9, 2016

Medical Training for Transgender Patients Needs to Include Sensitivity to Social Stigmas for both Gender and Sexual Orientation

The recently published article on doctor’s lack of expertise in treating transgender patients in The Guardian is an important step forward in highlighting current disparities in healthcare services for this population.  The study, based on interviews with sample of 23 physicians and … Continue reading
September 8, 2016

Fordham RETI Fellow Addresses Stigma for HIV-Positive Gay and Bisexual Men

The minority stress theory suggests that health disparities experienced by gay and bisexual men (GBM) and other sexual minorities can be explained in terms of stigma-related stressors such as discrimination at work, school, religious institutions, communities and families. The unique … Continue reading
August 30, 2016

Will Research on 10,000 New Yorkers Fuel Future Racial Health Inequality?

By Celia B. Fisher, Ph.D. A 20-year, multi-million dollar study of more than 10,000 New Yorkers scheduled to begin next year claims that it will enable the development of theories, therapeutics, and policies to improve the health and quality of … Continue reading
August 17, 2016

Weeding Out the Truth: DEA’s New Stance on Marijuana Largely the Same as the Old

by Craig Klugman, Ph.D.

According to the Department of Justice, marijuana offenses account for 12.5% of all people in federal prisons for drug offenses.…

August 15, 2016

Get the Public Involved in Chimera Research at NIH

by Carolyn Plunkett Neuhaus, Ph.D.

NIH is seeking public comment on a new policy regarding chimeras. From the Greek word for a fire-breathing animal with a lion’s head, a goat’s body, and a snake’s tail, “chimera” in this context means a non-human organism that has human components – such as human tissues or organs.…

June 21, 2016

Its not just mental health studies: Doctors rarely ask adolescent patients about their sexual orientation & LGBT youth are afraid of bias

A recent report underscores the paucity of mental health research relevant to LGBT patients.  According to Celia B. Fisher, Ph.D., Director of the Fordham University Center for Ethics Education this unfortunate situation is not unique to research studies. “In our … Continue reading
June 17, 2016

Best intentions, worst outcomes: Ethical and legal challenges for international research involving sex workers

Central America hosts a thriving sex work industry that is a key source and transit region for sex trafficking and undocumented migrants engaged in sex work. Sex workers – particularly those who are migrant – are at high risk for … Continue reading
April 22, 2016

Dr. Celia B. Fisher Examines Whether IRBs Hinder HIV Research with LGBT Youth

The dearth of HIV prevention research on LGBT individuals under 18 years of age is at least partially a result of conservative Institutional Review Boards (IRBs), according to new research by Fordham University Center for Ethics Education Director Dr. Celia … Continue reading
April 7, 2016

BioethicsTV: “Heartbeat” tackles therapeutic misconception

by Craig Klugman, Ph.D.

On episode 4 of Heartbeat, the heroine, Dr. Panttiere has received hospital funding to try an experimental cancer treatment on 5 patients.…

April 7, 2016

Fisher describes innovative approach to research involving vulnerable adolescents at OHRP conference

Fordham University Center for Ethics Education Director and Marie Ward Doty University Chair in Ethics Dr. Celia B. Fisher gave the keynote address this morning at an Office for Human Research Protections (OHRP) conference, entitled “Vulnerable, Marginalized and At-Risk Participants in … Continue reading

View More Blog Entries

Published Articles (188)

American Journal of Bioethics: Volume 16 Issue 10 - Oct 2016

Healing Without Waging War: Beyond Military Metaphors in Medicine and HIV Cure Research Jing-Bao Nie, Adam Gilbertson, Malcolm de Roubaix, Ciara Staunton, Anton van Niekerk, Joseph D. Tucker & Stuart Rennie

AJOB Neuroscience: Volume 7 Issue 2 - Apr 2016

The Arts and Sciences of Reading: Humanities in The Laboratory Lindsey Grubbs

AJOB Neuroscience: Volume 7 Issue 2 - Apr 2016

The Relevance and Context of Research Laura Otis

AJOB Primary Research: Volume 7 Issue 3 - Jul 2016

Ethical challenges in designing and implementing health systems research: Experiences from the field Adnan Hyder & Carleigh Krubiner

AJOB Primary Research: Volume 7 Issue 3 - Jul 2016

Promoting equity through health systems research in low- and middle-income countries: Practices of researchers Bridget Pratt, Katharine A. Allen & Adnan A. Hyder

AJOB Primary Research: Volume 7 Issue 3 - Jul 2016

Does promoting research advance planning in a general elderly population enhance completion of a research directive and proxies' predictive ability? a randomized controlled trial Gina Bravo, Lise Trottier, Marie-France Dubois, Marcel Arcand, Danièle Blanchette, Anne-Marie Boire-Lavigne, Maryse Guay, Paule Hottin, Julie Lane, Suzanne Bellemare & Karen Painter

AJOB Primary Research: Volume 7 Issue 3 - Jul 2016

Clarifying ethical responsibilities in pediatric biobanking Merle Spriggs & Craig L. Fry

AJOB Primary Research: Volume 7 Issue 3 - Jul 2016

Lay attitudes toward trust, uncertainty, and the return of pediatric research results in biobanking John Lynch, Janelle Hines, Sarah Theodore & Monica Mitchell

American Journal of Bioethics: Volume 16 Issue 8 - Aug 2016

IRB and Research Regulatory Delays Within the Military Health System: Do They Really Matter? And If So, Why and for Whom? Michael C. Freed, Laura A. Novak, William D. S. Killgore, Sheila A. M. Rauch, Tracey P. Koehlmoos, J. P. Ginsberg, Janice L. Krupnick, Albert "Skip" Rizzo, Anne Andrews & Charles C. Engel

American Journal of Bioethics: Volume 16 Issue 6 - Jun 2016

Clinical Trials Infrastructure as a Quality Improvement Intervention in Low- and Middle-Income Countries Avram Denburg, Carlos Rodriguez-Galindo & Steven Joffe

View More Articles

News (376)

September 15, 2016 8:00 am

Stop ignoring misconduct (Nature)

The history of science shows that irreproducibility is not a product of our times. Some 350 years ago, the chemist Robert Boyle penned essays on “the unsuccessfulness of experiments”. He warned readers to be sceptical of reported work. “You will meet with several Observations and Experiments, which … may upon further tryal disappoint your expectation.” He attributed the problem to a ‘lack of skill in the scientist and the lack of purity of the ingredients’, and what would today be referred to as inadequate statistical power.

September 14, 2016 8:00 am

How the Sugar Industry Shifted Blame to Fat (NY Times)

The sugar industry paid scientists in the 1960s to play down the link between sugar and heart disease and promote saturated fat as the culprit instead, newly released historical documents show.

September 9, 2016 8:00 am

Another scathing report causes more eminent heads to roll in the Macchiarini scandal (Science)

The scandal surrounding Paolo Macchiarini, the former star surgeon who became famous for his pioneering trachea transplants, has prompted yet another round of resignations and firings at the highest levels of Swedish higher education. On Monday evening, Swedish Minister for Higher Education and Research Helene Hellmark Knutsson said she had dismissed the country’s chancellor in charge of all public universities, Harriet Wallberg-Henriksson, following the release of a sharply critical report by an independent commission that examined the Karolinska Institute’s (KI’s) hiring and management of Macchiarini. Wallberg-Henriksson was vice-chancellor of KI in Stockholm, a position comparable to that of a university president, when Macchiarini was hired, and played a key role in his recruitment.

September 9, 2016 8:00 am

Blue ribbon report urges U.S. cancer moonshot to invest in 10 promising areas (Science)

Vice President Joe Biden’s proposed moonshot to conquer cancer should invest in large collaborations, data sharing projects, and the promising cancer treatment known as immunotherapy, among 10 areas described in an advisory group’s draft report released this morning. The report was accepted (with one abstention) today by the National Cancer Institute’s (NCI’s) advisory board, which is expected to pass it on to the NCI director and then to a federal task force. Now, Congress just needs to come up with the money to pay for the moonshot, research advocates say.

August 9, 2016 8:00 am

Beyond CRISPR: A guide to the many other ways to edit a genome (Nature)

The CRISPR–Cas9 tool enables scientists to alter genomes practically at will. Hailed as dramatically easier, cheaper and more versatile than previous technologies, it has blazed through labs around the world, finding new applications in medicine and basic research.

August 8, 2016 11:58 am

NIH Plans To Lift Ban On Research Funds For Part-Human, Part-Animal Embryos (NPR)

The federal government announced plans Thursday to lift a moratorium on funding of certain controversial experiments that use human stem cells to create animal embryos that are partly human.

August 5, 2016 12:19 pm

Medical Studies Involving Children Often Go Unpublished (NPR)

Many medical studies involving children never end up being put to use because scientists frequently don’t publish the results of their work, according to an analysis published online Thursday.

August 3, 2016 8:00 am

Young blood antiaging trial raises questions (Science)

It was one of the most mind-bending scientific reports in 2014: Injecting old mice with the plasma portion of blood from young mice seemed to improve the elderly rodents’ memory and ability to learn. Inspired by such findings, a startup company has now launched the first clinical trial in the United States to test the antiaging benefits of young blood in relatively healthy people. But there’s a big caveat: It’s a pay-to-participate trial, a type that has raised ethical concerns before, most recently in the stem cell field.

July 28, 2016 8:17 am

Europe overhauls rules for ‘first-in-human’ trials in wake of French disaster (Science)

The European Union is beefing up protections for volunteers in phase I clinical trials in the wake of a disastrous clinical study in Rennes, France, that resulted in the death of one volunteer and the hospitalization of five others. On 21 July, the European Medicines Agency (EMA) in London announced in a “concept paper” that it wants to improve strategies to identify and reduce risks in “first-in-human” (FIH) studies on healthy volunteers. EMA is asking for input from stakeholders.

May 12, 2016 8:14 am

For cholesterol study volunteer, an unsettling discovery in a Science paper: herself (Science)

When I first meet Rita Woidislawsky at La Colombe, her favorite coffee shop steps from Philadelphia, Pennsylvania’s upscale Rittenhouse Square, she’s effusive and bracingly direct—hugging patrons she knows, waving to baristas, and quickly finding the one table that’s about to free up. She’s dressed in workout clothes and delights in looking younger than her 68 years, with curly hair and an Israeli accent that’s lingered since she emigrated in her late teens.

View More News Items